| Structure |
Chemical Name |
CAS |
MF |
 |
Ixazomib Impurity |
|
|
|
|
Nevirapine Impurity |
|
|
 |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
 |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |
 |
Sitagliptin EP Impurity C |
1345822-86-7 |
C16H19F5N5O5P |
 |
Trifluridine Impurity |
2086328-10-9 |
C10H11F3N2O5 |
|
|
Valsartan related compound H |
|
|
 |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
|
|
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](/CAS/20180703/GIF/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |
 |
Merariveron impurity D |
|
C26H28N6O3S2 |
|
|
Cefazolin impurity E |
|
|
|
|
Lamivudine Impurity Mixture |
|
|
 |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
 |
4-(3-(Piperidin-1-yl)propoxy)benzoic acid |
767286-87-3 |
C15H21NO3 |
 |
5-Chloro-3-sulfino-2-thiophenecarboxylic acid |
187746-97-0 |
C5H3ClO4S2 |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
 |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
 |
34-Methylcyanocobalamin |
38218-51-8 |
C64H90CoN14O14P |
|
|
Empagliflozin Impurity D |
|
|
|
|
Ipragliflozin Impurity 2 |
|
|
|
|
Nicergoline EP impurity F |
|
|
|
|
Mirabegron Impurity 4 |
|
|
 |
Bisoprolol EP Impurity D |
1225195-71-0 |
C26H40N2O5 |
 |
Febuxostat Descyano Impurity |
1206550-99-3 |
C15H17NO3S |
![(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one](/CAS/20200119/GIF/14639-79-3.gif) |
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one |
14639-79-3 |
C19H28O |
 |
Cefuroxime Sodium Impurity |
|
C16H16N4NaO8S |
 |
2-Bromo (S)-Carbidopa |
43197-33-7 |
C10H13BrN2O4 |
 |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
 |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
 |
Famotidine EP Impurity A |
88061-72-7 |
C8H15N7O2S3 |
 |
Meloxicam EP Impurity D |
1331636-17-9 |
C16H17N3O4S2 |
 |
Erythromycin Impurity |
40554-78-7 |
C37H65NO12 |
 |
Fluconazole EP Impurity I |
150168-54-0 |
C13H14BrF2N7O |
 |
1-benzyl-2-methyl-1H-imidazole-carbaldehyde |
39269-74-4 |
C12H12N2O |
 |
Sacubitril Impurity |
1015037-46-3 |
C23H27NO4 |
 |
Desloratadine Impurity |
50603-12-8 |
C20H21N |
|
|
Olaparib Impurity H |
|
|
|
|
Brexpiprazole Impurity B |
|
|
|
|
Dapoxetine iMpurity 6 |
|
|
 |
Irbesartan Impurity 4 |
|
C25H28N6O |
 |
2-cyclopentylidene-2-phenylacetic acid |
|
C13H14O2 |
|
|
Cabozantinib impurity B |
|
|
 |
Metoprolol IMpurity 3 |
|
C15H25NO3 |
|
|
Mirabegron Impurity 1 |
|
|
 |
Desfluoro Pitavastatin Calcium |
847849-67-6 |
C25H25NO4 |
 |
Plerixafor |
548488-49-9 |
C12H23F3N4O |
|
|
Vonoprazan Impurity 10 |
|
|
|
|
Vonoprazan Impurity 5 |
|
|
|
|
Sitagliptin IMpurity 1 |
|
|
|
|
Etoricoxib Impurity 7 |
|
|
|
|
Ezetimibe Impurity D |
|
|
|
|
Erlotinib Imp.18 |
|
|
 |
Ezetimibe (RSS)-Isomer |
1478664-18-4 |
C24H21F2NO3 |
 |
Eliglustat intermediate 3 |
491833-26-2 |
C23H28N2O5 |
 |
Aztreonam Impurity B |
102586-36-7 |
C13H19N5O6S |
 |
Olopatadine impurity |
3112735-87-9 |
C20H20N2O4 |
 |
Voriconazole Impurity 8 |
239807-03-5 |
C16H14F3N5O |
|
|
Caspofungin impurity 3 |
|
|
|
|
Plerixafor Impurity D |
|
|
 |
Cefuroxime impurity 1 |
|
C16H16N4O8S |
|
|
Vonoprazan Impurity 9 |
|
|
|
|
Sitagliptin IMpurity 5 |
|
|
|
|
Brexpiprazole Impurity3 |
|
|
 |
Levetiracetam impurity 5 |
1543300-90-8 |
C9H17NO4 |
|
|
Febuxostat Impurity B |
|
|
|
|
Sorafenib Impurity F |
|
|
 |
Trelagliptin Impurity 1 |
1821400-07-0 |
C21H13ClF2N4O2 |
 |
Vortioxetine Imp.J |
2137588-68-0 |
C18H22N2S |
 |
4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
1608459-56-8 |
C18H27N3O3 |
 |
4,5-dichloro Rivaroxaban |
2305917-61-5 |
C25H28ClN3O6S |
 |
Solifenacin EP Impurity B |
1534326-81-2 |
C31H28N2O |
 |
Vildagliptin Impurity 6 |
1846606-31-2 |
C17H23N3O2 |
|
|
Flucloxacillin Impurity A |
|
|
|
|
Nicorandil Impurity 1 |
|
|
|
|
Piperacillin Impurity 6 |
|
|
 |
Bosutinib Impurity 5 |
1391063-17-4 |
C26H29Cl2N5O3 |
|
|
Levomilnacipran impurity |
|
|
|
|
Sofosbuvir IMpurity 4 |
|
|
 |
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
 |
6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one |
1340024-54-5 |
C14H18O |
 |
Edoxaban impurity 1 |
41374-72-5 |
C9H10N2O3 |
|
|
Canagliflozin Impurity 18 |
|
|
|
|
Canagliflozin Impurity 23 |
|
|
|
|
Carfilzomib Impurity 4 |
|
|
 |
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
 |
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
 |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
 |
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
 |
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
 |
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
 |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
 |
6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine |
1145671-52-8 |
C20H23N3O4 |
 |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
 |
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
 |
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
 |
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
 |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
 |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
 |
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |